Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Mogamulizumab

EU orphan designation number: EU/3/11/943   
Active ingredient: Mogamulizumab
Indication: Treatment of peripheral T-cell lymphoma (nodal, other extranodal and leukaemic/disseminated)
Sponsor: ProStrakan Limited
Galabank Business Park, Galashiels TD1 1QH, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/01/2012 Centralised Orphan - Designation EMA/OD/104/11 (2012)129 of 11/01/2012
26/04/2012 Centralised Orphan - Transfer of orphan designation EMA/OD/104/11/T/01 (2012)2899 of 23/04/2012